ATF3 and prostate carcinoma: Several reports indicated that ATF3 expression is downregulated in a variety of human cancers, including colon cancer [7], liver cancer [8], multiple myeloma [9], neuroblastoma [10], bladder cancer [11], prostate cancer [12], malignant glioma [13] and non-small cell lung carcinoma [14].